MA29950B1 - Nouveau derive de la pleuromutiline et son utilisation - Google Patents

Nouveau derive de la pleuromutiline et son utilisation

Info

Publication number
MA29950B1
MA29950B1 MA30929A MA30929A MA29950B1 MA 29950 B1 MA29950 B1 MA 29950B1 MA 30929 A MA30929 A MA 30929A MA 30929 A MA30929 A MA 30929A MA 29950 B1 MA29950 B1 MA 29950B1
Authority
MA
Morocco
Prior art keywords
compound
skin
pleuromutiline
respiratory tract
infections
Prior art date
Application number
MA30929A
Other languages
English (en)
Inventor
David H Igo
Beth A Norton
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA29950B1 publication Critical patent/MA29950B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/66—Y being a hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C07C2603/82—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRÉSENTE INVENTION CONCERNE LE SEL L-TARTRATE DU TRANS-3-AMINOCYCLOBUTYL (LS,2R,3S,4S:,6R,7R,8R-,14R)-4-ÉTHÉNYL-3-HYDROXY-2,4,7, 14-TÉTRAMÉTHYL-9-OXOTRICYCLO[5.4.3.01,8]TÉTRADEC-6-YL IMIDO DICARBONATE (COMPOSÉ IA). LE COMPOSÉ IA EST UTILISABLE POUR LE TRAITEMENT DE MALADIES ET D'ÉTATS VARIÉS TELS QUE DES INFECTIONS DES VOIES RESPIRATOIRES ET DE LA PEAU ET DES STRUCTURES CUTANÉES. EN CONSÉQUENCE, L'INVENTION CONCERNE EN OUTRE DES COMPOSITIONS PHARMACEUTIQUES COMPRENANT LE COMPOSÉ IA. L'INVENTION CONCERNE DE PLUS DES PROCÉDÉS DE TRAITEMENT D'INFECTIONS DES VOIES RESPIRATOIRES ET DE LA PEAU ET DES STRUCTURES CUTANÉES À L'AIDE DU COMPOSÉ IA OU D'UNE COMPOSITION PHARMACEUTIQUE COMPRENANT LE COMPOSÉ IA.
MA30929A 2005-11-18 2008-05-15 Nouveau derive de la pleuromutiline et son utilisation MA29950B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73830805P 2005-11-18 2005-11-18

Publications (1)

Publication Number Publication Date
MA29950B1 true MA29950B1 (fr) 2008-11-03

Family

ID=38068017

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30929A MA29950B1 (fr) 2005-11-18 2008-05-15 Nouveau derive de la pleuromutiline et son utilisation

Country Status (14)

Country Link
US (1) US20080269342A1 (fr)
EP (1) EP1951671A4 (fr)
JP (1) JP2009516704A (fr)
KR (1) KR20080080125A (fr)
CN (1) CN101360712A (fr)
AR (1) AR058197A1 (fr)
AU (1) AU2006318238A1 (fr)
BR (1) BRPI0618775A2 (fr)
CA (1) CA2630254A1 (fr)
CR (1) CR9991A (fr)
EA (1) EA200801364A1 (fr)
MA (1) MA29950B1 (fr)
TW (1) TW200736203A (fr)
WO (1) WO2007062333A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2683684B1 (fr) * 2011-03-08 2018-01-03 GE Healthcare Limited Préparation d'un dérivé d'acide 1-amino-3-hydroxy-cyclobutane-1-carboxylique
CN102813629A (zh) * 2012-08-29 2012-12-12 湖北龙翔药业有限公司 一种酒石酸沃尼妙林预混剂的制备方法
CN103641702B (zh) * 2013-11-18 2015-11-18 宁夏泰瑞制药股份有限公司 一种截短侧耳素的水解方法
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
WO2018152408A1 (fr) * 2017-02-17 2018-08-23 University Of Tennessee Research Foundation Dérivés de pleuromutiline et leurs utilisations
CN111662220A (zh) * 2020-04-20 2020-09-15 常州安蒂卫生物科技有限公司 用于治疗新型冠状病毒肺炎继发细菌感染性疾病的截短侧耳素类化合物
EP4338732A1 (fr) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin et ses dérivés pour leur utilisation dans le traitement de la tularémie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1182449A1 (fr) * 2000-08-21 2002-02-27 Motorola, Inc. Appareil et méthode pour gérer un circuit intégré
US20030219461A1 (en) * 2000-09-12 2003-11-27 Britten Nancy J. Parenteral combination therapy for infective conditions
GB0024811D0 (en) * 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
US6750064B2 (en) * 2000-12-28 2004-06-15 S.S.C.I. Inc. Methods of screening for possible solid forms

Also Published As

Publication number Publication date
WO2007062333A2 (fr) 2007-05-31
BRPI0618775A2 (pt) 2011-09-13
JP2009516704A (ja) 2009-04-23
US20080269342A1 (en) 2008-10-30
CR9991A (es) 2008-07-29
EA200801364A1 (ru) 2009-02-27
CN101360712A (zh) 2009-02-04
KR20080080125A (ko) 2008-09-02
TW200736203A (en) 2007-10-01
AU2006318238A1 (en) 2007-05-31
EP1951671A4 (fr) 2010-06-09
CA2630254A1 (fr) 2007-05-31
EP1951671A2 (fr) 2008-08-06
AR058197A1 (es) 2008-01-23
WO2007062333A3 (fr) 2007-11-08

Similar Documents

Publication Publication Date Title
EP1562897A4 (fr) Inhibiteurs de beta-secretase phenylcarboxamide utilises dans le traitement de la maladie d'alzheimer
TNSN03130A1 (fr) Inhibiteurs de protease du vih, compositions les contenant, leurs utilisations pharmaceutiques et matieres pour leur synthese
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
EP1673078A4 (fr) Inhibiteurs de type benzylether et benzylamino de beta-secretase pour le traitement de la maladie d'alzheimer
MA49673B1 (fr) Combinaison comprenant du palbociclib et 6-(2,4-dichlorophényl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulène-2-acide carboxylique et sa utilisation pour le traitement du cancer
MXPA04003007A (es) Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades.
ATE368031T1 (de) Neue gamma secretase inhibitoren
TNSN00092A1 (fr) Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant
EP1638950A4 (fr) Derives de cyclohexylglycine servant d'inhibiteurs de la dipeptidyl peptidase pour le traitement ou la prevention du diabete
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
MA27774A1 (fr) Inhibiteurs de phosphatidylinositol 3-kinase
EP1589969A4 (fr) Derives d'acide 3-amino-4-phenylbutanoique utilises comme inhibiteurs de la dipeptidyl peptidase pour le traitement ou la prevention du diabete
TN2010000175A1 (fr) Piperidino-dihydrothienopyrimidines substituees
MA33076B1 (fr) Utilisation d'un inhibiteur de la gamma-secretase pour le traitement du cancer
TNSN99172A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA33365B1 (fr) Dérivés de spiro[2.4]heptane pontés utiles en tant qu'agonistes du récepteur de alx et/ou du récepteur fprl2
MA30089B1 (fr) (arylsulfonyl)-pyrasolopiperidines
MA26960A1 (fr) Sels d'un isothiazole-4-carboxamide et leur utilisation comme agent anti-hyperproliferation
TNSN98238A1 (fr) Macrolides nouveaux
EP1689713A4 (fr) Inhibiteurs de benzylether et benzylamino de beta-secretase pour traiter la maladie d'alzheimer
MA30351B1 (fr) Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation
MA28742B1 (fr) Derives de pyrido-pyrimidine, leur preparation, leur application en therapeutique
MA29543B1 (fr) Procedes pour traiter un cancer pharmacoresistant
MA34545B1 (fr) Co-cristaux et sels d'inhibiteurs de ccr3
TNSN00235A1 (fr) Derives d'heterocyclo-alkylsulfonylpyrazole nouveaux, procede pour leur preparation et compositions les contenant